Dnajb1 gene expression was significantly downregulated in early-stage BC compared with non-diseased breast cells (p < 0.01) and was not significantly upregulated in the late-stage BC compared to JL-Contra-3 and JL-BRL-6 (p = 0.4). The gene discussed is DNAJB1; the disease is breast cancer.